244 related articles for article (PubMed ID: 25895847)
1. Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome.
Efthymiou M; Lawrie AS; Mackie I; Arachchillage D; Lane PJ; Machin S; Cohen H
Thromb Res; 2015 Jun; 135(6):1191-7. PubMed ID: 25895847
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
[TBL] [Abstract][Full Text] [Related]
3. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
Crowl A; Schullo-Feulner A; Moon JY
Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
[TBL] [Abstract][Full Text] [Related]
4. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
[TBL] [Abstract][Full Text] [Related]
5. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Arachchillage DR; Mackie IJ; Efthymiou M; Chitolie A; Hunt BJ; Isenberg DA; Khamashta M; Machin SJ; Cohen H
J Thromb Haemost; 2016 Nov; 14(11):2177-2186. PubMed ID: 27541499
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Cohen H; Efthymiou M; Devreese KMJ
J Thromb Haemost; 2021 Apr; 19(4):892-908. PubMed ID: 33325604
[TBL] [Abstract][Full Text] [Related]
8. Use of direct oral anticoagulants in antiphospholipid syndrome.
Cohen H; Efthymiou M; Isenberg DA
J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
[TBL] [Abstract][Full Text] [Related]
9. Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.
Bijsterveld NR; Middeldorp S; Berends F; Büller HR
J Thromb Thrombolysis; 2000 Apr; 9(3):263-9. PubMed ID: 10728026
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.
Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
Thromb Res; 2015 Feb; 135(2):388-93. PubMed ID: 25555316
[TBL] [Abstract][Full Text] [Related]
11. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
Nilsson CU; Strandberg K; Reinstrup P
Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
[TBL] [Abstract][Full Text] [Related]
12. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.
Lawrie AS; Purdy G; Mackie IJ; Machin SJ
Br J Haematol; 1997 Sep; 98(4):887-92. PubMed ID: 9326184
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
Perry SL; Samsa GP; Ortel TL
Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
[TBL] [Abstract][Full Text] [Related]
15. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.
Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
J Thromb Haemost; 2014 Nov; 12(11):1801-9. PubMed ID: 25196808
[TBL] [Abstract][Full Text] [Related]
16. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
17. Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing.
Baumann Kreuziger LM; Datta YH; Johnson AD; Zantek ND; Shanley R; Reding MT
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):232-6. PubMed ID: 24681704
[TBL] [Abstract][Full Text] [Related]
18. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome.
Fonseca MES; Balbi GGM; Signorelli F; Gouvea CP; de Andrade DCO
Lupus; 2022 Apr; 31(5):565-574. PubMed ID: 35266798
[TBL] [Abstract][Full Text] [Related]
19. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins.
Tripodi A; Chantarangkul V; Clerici M; Negri B; Galli M; Mannucci PM
Br J Haematol; 2001 Dec; 115(3):672-8. PubMed ID: 11736953
[TBL] [Abstract][Full Text] [Related]
20. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
